Vaccination Cuts Risk for Myocardial Infarction, Stroke 31 to 120 Days After COVID-19
Full vaccination against COVID-19 is associated with a lower risk for acute myocardial infarction and ischemic stroke 31 to 120 days after COVID-19.
Full vaccination against COVID-19 is associated with a lower risk for acute myocardial infarction and ischemic stroke 31 to 120 days after COVID-19.
Older women with more advanced abdominal aortic calcification (AAC) have a higher risk for late-life dementia.
Compared with nonoperative atrial fibrillation, postoperative AF after noncardiac surgery is associated with a similar risk for stroke or transient ischemic attack.
In a retrospective, observational study, researchers examined the association between long-term neurologic outcomes and serum sodium levels in patients who survived OHCA.
Investigators evaluated LAA closure with the WATCHMAN FLX device versus oral anticoagulation following percutaneous catheter ablation for nonvalvular AF.
A study was conducted to determine the relationship between management of patients with DM hospitalized for AMI and vascular outcomes.
There is no evidence of an increased risk for MACE after vaccination with BNT162b2 or CoronaVac in patients with CVD.
Cardiometabolic disease (CMD) multimorbidity accelerates cognitive decline and conversion to dementia.
Stroke survivors who participate in a comprehensive stroke recovery program that incorporates modified cardiac rehabilitation have decreased all-cause mortality at 1 year, improved overall function, and better cardiovascular performance.
Beta-blocker pharmacokinetics comparison chart for hypertension.